Bristol Myers Squibb

Page 2 of 3

Key Speakers At The 2017 Milken Conference
Newsletters

Bristol Myers Squibb and Celgene got a beating in Congress on drug prices—but only Congress can fix the problem

By
October 1, 2020
Diversity is long overdue in the drug industry—and it’s going to take more than just hiring Black candidates
Health

Diversity is long overdue in the drug industry—and it’s going to take more than just hiring Black candidates

By
August 12, 2020
American Vasant Narasimhan, CEO of Swiss pharmaceutical and drug maker Novartis speaks during a conference at the Fortune Global Forum event in Paris on Nov. 18, 2019. (Photo by ERIC PIERMONT / AFP) (Photo by ERIC PIERMONT/AFP via Getty Images)
Newsletters

Healthcare is in the midst of a ‘paradigm shift’

By Katherine Dunn and Alan Murray
July 8, 2020
Brainstorm Health 2020-Giovanni Caforio-Vas Narasimhan
Conferences

Will the pharmaceutical industry keep collaborating after COVID-19? Novartis and Bristol Myers Squibb CEOs say it has to

By
July 7, 2020
5 companies to keep an eye on following the world’s largest cancer conference
Health

5 companies to keep an eye on following the world’s largest cancer conference

By
June 3, 2020
Fitbit BMS Pfizer AFib
Newsletters

Fitbit Teams Up With Drug Giants to Tackle a Serious Heart Condition: Brainstorm Health

By
October 17, 2019
FDA drug approvals Roche Celgene AbbVie
Newsletters

The FDA Went on an Epic Drug Approval Binge This Week: Brainstorm Health

By
August 16, 2019
BMS Celgene acquisition
Health

Bristol-Myers Squibb Loses $6 Billion in Value on Celgene Deal Setback: Brainstorm Health

By
June 24, 2019
Laboratory for production of cancer drug

Bristol-Myers Is Buying Celgene for $74 Billion in One of the Largest Big Pharma Mergers Ever

By
January 3, 2019
CHINA-ECONOMY-CREDI-LOANS-DEBT-GOVERNMENT
Health

A Cancer Blockbuster Gets Approved in China. Will the Floodgates Now Open?

By
June 15, 2018
Lung cancer on the left pulmonary lobe, seen on a frontal X-ray of the chest.
Health

Merck’s Bet on Cancer Immunotherapy Is Paying Off in Spades and Helping Lung Cancer Patients Live Longer

By
April 16, 2018
This Lung Cancer Drug Could Let Patients Forgo Chemo—And It’s Sending Merck’s Stock Soaring
Health

This Lung Cancer Drug Could Let Patients Forgo Chemo—And It’s Sending Merck’s Stock Soaring

By
April 9, 2018
US-ECONOMY-STOCK MARKET
Health

Why Cancer Drug Maker Incyte’s Stock Plunged—And Took Others Down With It

By
April 6, 2018
Delivering Alpha - Season 2016
Health

Bristol-Myers Squibb Shares Just Spiked on Reports of a Carl Icahn Stake

By
February 21, 2017
Trading On The Floor Of The NYSE As U.S. Stocks Decline With Banks, Health Shares Lower
Health

Why These Two Pharma Stocks Are Having Drastically Different Days

By
January 20, 2017

Most Popular